Business Description
MedCap AB
ISIN : SE0009160872
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.81 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | 0.74 | |||||
Interest Coverage | 16.29 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 8.35 | |||||
Beneish M-Score | -2.19 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23.3 | |||||
3-Year EBITDA Growth Rate | 27.7 | |||||
3-Year EPS without NRI Growth Rate | 38 | |||||
3-Year FCF Growth Rate | 26 | |||||
3-Year Book Growth Rate | 19.7 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.24 | |||||
Quick Ratio | 1.48 | |||||
Cash Ratio | 0.62 | |||||
Days Inventory | 140.61 | |||||
Days Sales Outstanding | 58.33 | |||||
Days Payable | 103.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.1 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 59.43 | |||||
Operating Margin % | 15.33 | |||||
Net Margin % | 12.18 | |||||
FCF Margin % | 13.09 | |||||
ROE % | 20.65 | |||||
ROA % | 12.6 | |||||
ROIC % | 17.01 | |||||
ROC (Joel Greenblatt) % | 50.97 | |||||
ROCE % | 21.68 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 36.16 | |||||
PE Ratio without NRI | 36.16 | |||||
Shiller PE Ratio | 107.03 | |||||
Price-to-Owner-Earnings | 32.23 | |||||
PEG Ratio | 1.28 | |||||
PS Ratio | 4.45 | |||||
PB Ratio | 6.76 | |||||
Price-to-Tangible-Book | 16.65 | |||||
Price-to-Free-Cash-Flow | 34 | |||||
Price-to-Operating-Cash-Flow | 27.72 | |||||
EV-to-EBIT | 28.3 | |||||
EV-to-EBITDA | 20.46 | |||||
EV-to-Revenue | 4.69 | |||||
EV-to-FCF | 34.08 | |||||
Price-to-Projected-FCF | 3.41 | |||||
Price-to-DCF (Earnings Based) | 0.52 | |||||
Price-to-DCF (FCF Based) | 0.71 | |||||
Price-to-Median-PS-Value | 2.48 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.45 | |||||
Price-to-Graham-Number | 5.17 | |||||
Price-to-Net-Current-Asset-Value | 47.47 | |||||
Earnings Yield (Greenblatt) % | 3.53 | |||||
FCF Yield % | 2.81 | |||||
Forward Rate of Return (Yacktman) % | 21.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MedCap AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 1,668.9 | ||
EPS (TTM) (kr) | 13.8 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (kr) | 0 | ||
20-Day SMA (kr) | 272 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (kr) | 272 - 272 | ||
Shares Outstanding (Mil) | 14.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MedCap AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MedCap AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
MedCap AB Frequently Asked Questions
What is MedCap AB(CHIX:MCAPs)'s stock price today?
When is next earnings date of MedCap AB(CHIX:MCAPs)?
Does MedCap AB(CHIX:MCAPs) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |